Adenoid cystic carcinoma (ACC) of the breast rarely metastasizes and has been associated with excellent prognosis. We describe a patient with renal metastasis of primary breast ACC five years after the mastectomy. A detailed molecular genetic analysis of the primary and metastatic tumors demonstrated somatic mutations in two well known cancer genes associated with regulation of PI3K/AKT signaling pathway: 1) PIK3CA which encodes the catalytic alpha subunit of the phosphoinositide-3-kinase and 2) PTEN, which encodes phosphatase and tensin homolog. The mutation identified in PIK3CA (Ex1+169 A>C) predicts an amino acid change from isoleucine to methionine at codon 31 (131M) and resides in the p85-binding domain of exon 1. The mutation identified in PTEN (IVS4-3 C>T) resides in intron 4 near the splice acceptor site of exon 5 and was associated with an aberrant PTEN transcript lacking exon 5, which is necessary for protein tyrosine phosphatase function and tumor suppressor properties of PTEN. Increased promoter methylation of PTEN was present in renal metastasis, coinciding with the decrease in the level of normal PTEN transcript.
INTRODUCTION
Adenoid cystic carcinoma (ACC) of the breast is a rare histologic type of breast carcinoma, comprising less than 1% of all mammary carcinomas. 1 ACC is a basal-like breast carcinoma characterized by a distinct morphology and immunohistochemical profile. 2 ACC is usually associated with a very good prognosis. 3 Distant metastases are very rare and usually affect the lungs 1 . Only several cases with high grade tumors and distant metastases have been published, and only one case with symptomatic metastasis to the kidney has previously been reported. 4 We report here a case of ACC of the breast with symptomatic renal metastasis, and for the first time show coexistent mutations in genes encoding phosphoinositide-3-kinase catalytic alpha subunit (PIK3CA) and phosphatase and tensin homolog (PTEN). Both PIK3CA and PTEN are integral part of the mammalian target of rapamycin (mTOR) signaling pathway. 5 MTOR, a protein kinase of the PIK3/Akt signaling pathway, plays a central role in controlling malignant growth, cell cycle progression and proliferation.
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CASE HISTORY
76-year-old woman presented with abdominal pain, painless hematuria and urinary frequency. CT scan showed a 6 cm expansive, poorly circumscribed tumor of the right kidney that was considered a primary renal carcinoma. Radical nephrectomy was performed and subsequent pathologic examination revealed a 90x48x40 mm, gray-white, hemorrhagic tumor involving pelvicalyceal system and cortex and medulla of the upper part of the kidney.
Review of patient's medical records showed that she underwent a mastectomy at a different institution for 1. 8 cm primary mammary adenoid cystic carcinoma (pT1c N0 MX R0) 5 years prior to current surgery. The patient did not receive any adjuvant therapy. Original formalin fixed paraffin embedded (FFPE) tissue blocks were obtained and morphologic, immunohistochemical and molecular analyses were then performed to compare these 2 tumors.
METHODS
Immunohistochemistry
Immunohistochemistry was performed using the standard avidin-biotin complex (ABC) detection system and diaminobenzidine tetrahydrochloride (DAB) chromagen. Table 1 lists antibodies used and results of staining in both primary and metastatic tumors. The expression levels of cyclooxygenase-2 (COX-2) and PTEN were measured on immunohistochemically stained tissue slides using the Automated Cellular Imaging System (ACIS, ChromaVision
Medical Systems, Inc., San Juan Capistrano, CA). Mutation identification by DNA sequencing. PCR products were purified and cycle sequenced with amplicon specific primers. Sequencing products were run on an ABI 3100
Molecular genetic analysis
Genetic Analyzer. Data were analyzed using Sequencher (GeneCodes, Ann Arbor, MI) and by manual review of chromatograms.
PTEN cDNA analysis by RT-PCR.
The nucleotide sequences and exon-intron boundaries of PTEN and GAPDH were derived from NCBI (http://www3.ncbi.nlm.nih.gov/). Primers (SigmaGenosys, The Woodlands, TX) spanning exonic junctions were designed to amplify fragments representing selected regions of the PTEN coding sequence (Table 2) . RT-PCR was performed using the One-Step kit (Invitrogen, Carlsbad, CA) and end products were analyzed on the WAVE-HS and by DNA sequencing.
PTEN promoter methylation analysis by DHPLC and DNA sequencing.
The methylation status of the PTEN promoter was examined by analyzing the sequence context of PCR products obtained from sodium bisulfite modified genomic DNA. The sulfonated DNA was recovered using the Wizard DNA clean-up system (Promega, Madison, WI) and the conversion reaction was completed by desulfonating in 0.3 M NaOH for 10 minutes at room temperature. The DNA was ethanol precipitated and resuspended in water.
PCR was done using specific primers designed outside of any CpG islands to amplify both methylated and unmethylated promoter sequences. Final PCR products were analyzed by DHPLC on a WAVE System in which allelic differences in methylation are detected due to the sequence-dependent separation characteristics of the DNASep DHPLC column. To obtain information regarding differential methylation across the PTEN promoter region, PCR products were also bi-directionally sequenced. 
RESULTS
Microscopically
DISCUSSION
Although ACC shows a distinct morphological pattern, its diagnosis, particularly in the case of a remote, isolated renal metastasis, presents a significant diagnostic challenge.
Only one case with symptomatic renal and lung metastases has previously been reported. PIK3 proteins consist of the family of proteins divided intro three classes that differ in its structure, tissue distribution, mechanism of action and its function. The most important PIK3
proteins are those related to proliferation and carcinogenesis including class IA -the catalytic subunit p110α and its associated regulatory subunit p85. Activation of class IA proteins might activate several signaling pathways including AKT and Rictor-mTOR complex. 5, 11 PI3-AKT signals govern several transcription factors including forkhead box (FOXO) proteins and nuclear factor κB (NFκB). 13 NFκB acts as a positive regulator of cell survival, proliferation, cellular invasion and angiogenesis. Several studies demonstrated that Akt signals through NFκB in order to induce cyclooxygenase-2 (COX-2) expression in mutated PTEN tumor cells. 14 COX-2 significantly contributes to tumorigenesis through increased angiogenesis, invasiveness and inhibition of apoptosis. 14 Our case demonstrated higher COX-2 expression in the metastasis than in the primary tumor ( Figure 1A ).
Although PTEN gene is one of the most commonly mutated genes in human tumors, 15 its importance in ACC has not been described. Approximately 50% of breast carcinomas carry a mutation or loss of at least one copy of the PTEN gene which results in PIK3 activation. 16 PTEN mutations are often associated with an aggressive metastatic tumor phenotype since PTEN might interfere with focal adhesion kinase (FAK) and Shc functions enabling increased cell motility and spreading. 15 Inactivation of PTEN might also result in increased cell cycle progression through the Akt-dependent phosphorylation and inactivation of glycogen synthase kinase-3 (GSK-3) which, in turn, leads to cyclin D1 stabilization. 15 It also has a pivotal role in apoptosis since the loss of PTEN results in an increased PIP3 concentration and in Akt activation, leading to protection from various apoptotic stimuli. 15 In our case we demonstrated showed that mTOR inhibitors were well tolerated and might induce prolonged stable disease and tumor regressions in cancer patients. 5 Other components of this vital signaling pathway might also become the potential targets for specific small molecules. Thus, the mutated p110alpha proteins are ideal targets for such inhibitors that discriminate between the oncogenic and the wild-type forms of the enzyme. 
